We are live on ! Find out more
ASMB icon

Assembly Biosciences
ASMB

32 hedge funds and large institutions have $12M invested in Assembly Biosciences in 2023 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 10 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

19% more capital invested

Capital invested by funds: $10.1M → $12M (+$1.91M)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

0.26% less ownership

Funds ownership: 1.93% → 1.67% (-0.26%)

14% less funds holding

Funds holding: 37 → 32 (-5)

57% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 7

60% less repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 10

Holders
32
Holders Change
-5
Holders Change %
-13.51%
% of All Funds
0.5%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
3
Increased
4
Reduced
10
Closed
7
Calls
$17K
Puts
–
Net Calls
+$17K
Net Calls Change
-$36K

Top Buyers

1
Geode Capital Management
Geode Capital Management
Massachusetts
+$56.3K
2
EGM
Engineers Gate Manager
New York
+$10.3K
3
Northern Trust
Northern Trust
Illinois
+$9.95K
4
RhumbLine Advisers
RhumbLine Advisers
Massachusetts
+$2.46K
5
Morgan Stanley
Morgan Stanley
New York
+$381

Top Sellers

1
PIM
Platinum Investment Management
Australia
-$749K
2
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
-$239K
3
Hudson Bay Capital Management
Hudson Bay Capital Management
Connecticut
-$127K
4
Renaissance Technologies
Renaissance Technologies
New York
-$69.4K
5
Citadel Advisors
Citadel Advisors
Florida
-$48.4K
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$2.61M – – –
AIM
2
Alerce Investment Management
Illinois
$2.56M – – –
Millennium Management
3
Millennium Management
New York
$1.66M -$3.24K -264 -0.2%
BlackRock
4
BlackRock
New York
$1.23M -$16.6K -1,353 -1%
Hudson Bay Capital Management
5
Hudson Bay Capital Management
Connecticut
$950K -$127K -10,312 -13%
Renaissance Technologies
6
Renaissance Technologies
New York
$803K -$69.4K -5,650 -9%
Geode Capital Management
7
Geode Capital Management
Massachusetts
$584K +$56.3K +4,585 +12%
Federated Hermes
8
Federated Hermes
Pennsylvania
$393K -$21.7K -1,764 -6%
BCM
9
Bridgeway Capital Management
Texas
$200K – – –
State Street
10
State Street
Massachusetts
$167K – – –
Fidelity Investments
11
Fidelity Investments
Massachusetts
$162K -$17.6K -1,432 -11%
Acadian Asset Management
12
Acadian Asset Management
Massachusetts
$130K -$44.7K -3,641 -28%
Northern Trust
13
Northern Trust
Illinois
$124K +$9.95K +810 +10%
Citadel Advisors
14
Citadel Advisors
Florida
$108K -$48.4K -3,942 -34%
Franklin Resources
15
Franklin Resources
California
$95K – – –
Morgan Stanley
16
Morgan Stanley
New York
$51.5K +$381 +31 +0.8%
Barclays
17
Barclays
United Kingdom
$41.3K – – –
Charles Schwab
18
Charles Schwab
California
$37.3K – – –
Commonwealth Equity Services
19
Commonwealth Equity Services
Massachusetts
$21K – – –
Bank of New York Mellon
20
Bank of New York Mellon
New York
$18.2K – – –
Two Sigma Advisers
21
Two Sigma Advisers
New York
$17.1K -$18.6K -1,516 -55%
RC
22
RBF Capital
California
$15.9K – – –
Susquehanna International Group
23
Susquehanna International Group
Pennsylvania
$13.9K -$5.22K -425 -30%
HSBC Holdings
24
HSBC Holdings
United Kingdom
$12.8K – – –
EGM
25
Engineers Gate Manager
New York
$11.6K +$10.3K +839 New
1
2

ASMB Hedge Fund Activity: Q2 2023 in Review

32 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Assembly Biosciences (ASMB) for Q2 2023, worth a combined $12M — up 19% from $10.1M a quarter earlier.

Sellers outnumbered buyers: 7 funds closed out of ASMB and 3 opened new positions — a net loss of 4 holders — while 10 trimmed existing stakes and 4 added.

The largest buyer was Geode Capital Management, adding an estimated $56.3K. The largest seller was Platinum Investment Management, exiting entirely with an estimated $749K sold.

  • 32 institutional investors held Assembly Biosciences (ASMB) as of Q2 2023, down from 37 in Q1 2023.
  • Funds reported $12M of Assembly Biosciences stock for Q2 2023, up 19% quarter-over-quarter.
  • 3 funds opened new Assembly Biosciences positions in Q2 2023 and 7 closed out, a net change of -4 holders.
  • The largest Assembly Biosciences buyer in Q2 2023 was Geode Capital Management, an estimated $56.3K added.
  • The largest Assembly Biosciences seller in Q2 2023 was Platinum Investment Management, an estimated $749K sold.

Based on aggregated 13F filings for Q2 2023.